Abstract
Acute promyelocytic leukaemia (APL; FAB AML M3, Bennett et al. 1976) represents a unique example of a disease in which a successful treatment approach, in the form of all-trans retinoic acid (ATRA), has been developed that directly addresses and overcomes the causative molecular abnormality. For over a decade, retinoids have been noted to possess therapeutic activity which is virtually specific to the acute promyelocytic form of acute myeloid leukaemia (AML) (Breitman et al. 1981). Subsequent clinical trials have shown that ATRA can achieve remission rates of over 90% in APL (Huang et al. 1988; Castaigne et al. 1990; CHOMIENNE et al. 1990), representing an apparent significant improvement on results obtained with conventional chemotherapy; indeed a number of patients in these studies were chemoresistant or treated in relapse. Parallel in vitro studies have demonstrated that remission is achieved by terminal differentiation of the leukaemic clone rather than by a cytotoxic effect (Huang et al. 1988; Castaigne et al. 1990; Chomienne et al. 1990). This has been confirmed using clonal analysis of APL blasts and peripheral blood neutrophils following ATRA therapy (ELLIOTT et al. 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alcalay M, Zangrilli D, Pandolfi PP, Longo L, Mencarelli A, Giacomucci A, Rocchi M, Biondi A, Rambaldi A, Lo Coco F, Divedo D, Donti E, Grignani F, Pelicci PG (1991) Translocation break-point of acute promyelocytic leukemia lies within the retinoic acid receptor α locus. Proc Natl Acad Sci USA 88: 1977 – 1981
Alcalay M, Zangrilli D, Fagioli M, Pandolfi PP, Mencarelli A, Lo Coco F, Biondi A, Grignani F, Pelicci PG (1992) Expression pattern of the RARα-PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89: 4840 – 4844
Andersen B, Rosenfeld MG (1995) New wrinkles in retinoids. Nature 374: 118 – 119
Au-Fliegner M, Helmer E, Casanova J, Raaka BM, Samuels HH (1993) The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting het-erodimer but not homodimer formation. Mol Cell Biol 13: 5725 – 5737
Avvisati G, Ten Cate JW, Mandelli F (1992) Acute promyelocytic leukaemia. Br J Haematol 81: 315 – 320
Avvisati G, Baccarani M, Ferrara F, Lazzarino M, Resegotti L, Mandelli F (1994) AIDA protocol (all-transretinoic acid + idarubicin) in the treatment of newly diagnosed acute promyelocytic leukaemia: a pilot study of the Italian cooperative group GIMEMA. Blood 84 (Suppl 1 ): 380a
Bain BJ (1990) Leukaemia diagnosis. A guide to the FAB classification. Gower Medical, London, p 14
Barettino D, Bugge TH, Bartunek P, Vivanco Ruiz MdM, Sonntag-Buck V, Beug H, Zenke M, Stunnenberg HG (1993) Unliganded T3R, but not its oncogenic variant v-erbA, suppresses RAR dependent transactivation by titrating out RXR. EMBO J 12: 1343 – 1354
Beato M (1989) Gene regulation by steroid hormones. Cell 56: 335 – 344
Bennett J, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick NR, Sultan C (1976) [French-American-British (FAB) cooperative group]. Proposals for the classification of the acute leukaemias. Br J Haematol 33: 451–458
Berger R, Le Coniat M, Derré J, Vecchione D, Jonveaux P (1991) Cytogenetic studies in acute promyelocytic leukemia: a survey of secondary chromosomal abnormalities. Genes Chromosom Cancer 3: 332 – 337
Bhavnani M, Al Azzawi S, Liu Yin JA, Lucas GS (1994) Therapy-related acute promyelocytic leukaemia. Br J Haematol 86: 231 – 232
Biondi A, Rambaldi A, Pandolfi PP, Rossi V, Giudici G, Alcalay M, Lo Coco F, Diverio D, Pogliani EM, Lanzi EM, Mandelli F, Masera G, Barbui T, Pelicci PG (1992) Molecular monitoring of the myl/ retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 80: 492 – 497
Biondi A, Luciano A, Bassan R, Mininni D, Specchia G, Lanzi E, Castagna S, Cantu-Rajnoldi A, Liso V, Masera G, Barbui T, Rambaldi A (1993) CD2 expression correlates with microgranular acute promyelocytic leukemia (M3V) and not with PML gene breakpoint. Blood 82: 113a
Biondi A, Rovelli A, Cantu-Rajnoldi A, Fenu S, Basso G, Luciano A, Rondelli R, Mandelli F, Masera G, Testi AM (1994) Acute promyelocytic leukemia in children: experience of the Italian pediatric hematology and oncology group (AIEOP). Leukemia 8 (Suppl): s66 – s70
Biondi A, Luciano A, Bassan R, Mininni D, Specchia G, Lanzi E, Castagna S, Cantu-Rajnoldi A, Liso V, Masera G, Barbui T, Rambaldi A (1995) CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML breakpoint. Leukemia 9: 1461 – 1466
Boddy MN, Hoew K, Etkin LD, Solomon E. Freemont PS (1996) PIC 1, a novel ubiguitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acuted promyclockytic leukaemia. Oncogene (in press)
Borden KLB, Boddy MN, Lally J, O’Reilly NJ, Martin S, Howe K, Solomon E, Freemont PS (1995) The solution structure of the RING finger domain from the acute promyelocytic proto-oncoprotein PML. EMBO J 14: 1532 – 1541
Borden KLB, Lally JM, Martin SR, O’Reilly NJ, Solomon E, Freemont PS (1996) In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc Natl Acad Sci USA 93: 1601 – 1606
Borrow J, Goddard AD, Sheer D, Solomon E (1990) Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249: 1577 – 1580
Borrow J, Goddard AD, Gibbons B, Katz F, Swirsky D, Fioretos T, Dube I, Winfield DA, Kingston J, Hagemeijer A, Rees JKH, Lister TA, Solomon E (1992) Diagnosis of acute promyelocytic leukaemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts. Br J Haematol 82: 529 – 540
Borrow J, Solomon E (1992) Molecular analysis of the t(15; 17) translocation in acute promyelocytic leukaemia. Baillieres Clin Haematol 5: 833 – 856
Borrow J, Shipley J, Howe K, Kiely F, Goddard A, Sheer D, Srivastava A, Antony AC, Fioretos T, Mitelman F, Solomon E (1994) Molecular analysis of simple variant translocations in acute promyelocytic leukaemia. Genes Chromosom Cancer 9: 234 – 243
Brand NJ, Petkovich M, Chambon P (1990) Characterization of a functional promoter for the human retinoic acid receptor-alpha (hRAR-α). Nucleic Acids Res 18: 6799 – 6806
Breitman TR, Collins SJ, Keene BR (1981) Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 57: 1000 – 1004
Brockes J (1990) Reading the retinoid signals. Nature 345: 766 – 768
Burnett AK (1994) Karyotypically defined risk groups in acute myeloid leukaemia. Leuk Res 18: 889–890
Carvalho T, Seeler J-S, Ohman K, Jordan P, Pettersson U, Akusjärvi G, Carmo-Fonseca M, Dejean A (1995) Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J cell Biol 131: 45 – 56
Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76: 1704 – 1709
Castoldi GL, Liso V, Specchia G, Tomasi P (1994) Acute promyelocytic leukemia: morphological aspects. Leukemia 8 (Suppl): s27 – s32
Chelbi-Alix MK, Pelicano L, Quignon F, Koken MHM, Venturini L, Stadler M, Pavlovic J, Degos L, and de Thé H (1995) Induction of the PML protein by interferons in normal and APL cells. Leukemia 9: 2027 – 2033
Chen S-J, Zelent A, Tong J-H, Yu H-Q, Wang Z-Y, Derré J, Berger R, Waxman S, Chen Z (1993a) Rearrangements of the retinoic acid receptor alpha and promyelocytic leukaemia zinc finger genes resulting from t(11;17) (q23;q21) in a patient with acute promyelocytic leukaemia. J Clin Invest 91: 2260 – 2267
Chen Z, Brand NJ, Chen A, Chen S-J, Tong J-H, Wang Z-Y, Waxman S, Zelent A (1993b) Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-α locus due to a variant t(11; 17) translocation associated with acute promyelocytic leukaemia. EMBO J 12: 1161 – 1167
Chen Z, Guidez F, Rousselot P, Agadir A, Chen S-J, Wang Z-Y, Degos L, Zelent A, Waxman S, Chomienne C (1994a) PLZF-RARα fusion proteins generated from the variant t(11;17) (q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors. Proc Natl Acad Sci USA 91: 1178 – 1182
Chen Z, Morgan R, Stone JF, Sandberg AA (1994b) Identification of complex t(15; 17) in APL by FISH. Cancer Genet Cytogenet 72: 73 – 74
Chomienne C, Ballerini P, Balitrand N, Daniel MT, Fenaux P, Castaigne S, Degos L (1990) All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood 76: 1710 – 1717
Claxton DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Diesseroth AB (1992) Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood 80: 582 – 586
Collins SJ, Robertson KA, Mueller L (1990) Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukaemia cells is mediated directly through the retinoic acid receptor (RAR-α). Mol Cell Biol 10: 2154 – 2163
Damm K, Thompson CC, Evans RM (1989) Protein encoded by v-erb Afunctions as a thyroid hormone receptor antagonist. Nature 339: 593 – 597
Daniel MT, Koken M, Romagné O, Barbey S, Bazarbachi A, Stadler M, Guillemin MC, Degos L, Chomienne C, de Thé H (1993) PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82: 1858 – 1867
Danielan PS, White R, Lees JA, Parker MG (1992) Identification of a conserved region required for hormone-dependent transcriptional activation by steroid hormone receptors. EMBO J 11: 1025 – 1033
de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A (1990) The t(15; 17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 347: 558 – 561
de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A (1991) The PML-RARα fusion Mrna generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675 – 684
Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L (1994) Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. Leukemia 8 (Suppl): s71 – s76
Diverio D, Pandolfi PP, Biondi A, Avvisati G, Petti MC, Mandelli F, Pelicci PG, Lo Coco F (1993) Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission. Blood 82: 3556 – 3559
Don Chen J, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454 – 457
Dong S, Geng J-P, Tong J-H, Wu Y, Cai J-R, Sun G-L, Chen S-R, Wang Z-Y, Larsen C-J, Berger R, Chen S-J, Chen Z (1993) Breakpoint clusters of the PML gene in acute promyelocytic leukemia: Primary structure of the reciprocal products of the PML-RARA gene in a patient with t(15;17). Genes, Chromosom Cancer 6: 133 – 139
Doucas V, Brockes JP, Yaniv M, de Thé H, Dejean A (1993) The PML-retinoic acid receptor α translocation converts the recptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1. Proc Natl Acad Sci USA 90: 9345 – 9349
Doucas V, Ishov AM, Romo A, Juguilon H, Weitzman MD, Evans RM, Maul GG (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10: 196 – 207
Dulic V, Riezman H (1989) Characterization of the END 1gene required for vacuole biogenesis and gluconeogenic growth of budding yeast. EMBO J 8: 1349 – 1359
Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P (1994) Activation function 2 (AF-2) of RAR and RXR: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J 13: 5370 – 5382
Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A, Evans RM (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76: 333 – 343
Elliott S, Taylor K, White S, Rodwell R, Marlton P, Meagher D, Wiley J, Taylor D, Wright S, Timms P (1992) Proof of differentiative mode of action of all-transretinoic acid in acute promyelocytic leukemia using X linked clonal analysis. Blood 79: 1916 – 1919
Everett RD, Maul GG (1994) HSV-1 IE protein Vmw11O causes redistribution of PML. EMBO J 13: 5062 – 5069
Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A, Acampora D, Grignani F, Pelicci PG (1992) Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 7: 1083 – 1091
Fenaux P, Chastang C, Castaigne S, Archimbaud E, Sanz M, Link H, Guerci A, Fegueux N, Zittoun R, Stoppa AM, Travade P, Lamy T, Maloisel F, Sadoun A, San Miguel J, Veil A, Rayon C, Conde E, Fey M, Bordessoule D, Ganser A, Bowen D, Dreyfus F, Huguet F, Tilly H, Guy H, Auzanneau G, Chomienne C, Degos L (1994) Treatment of newly diagnosed acute promyelocytic leukemia (APL) with all-transretinoic acid (ATRA) followed by intensive chemotherapy (CT). Updated results of the European group. Blood 84: (Suppl): 379a
Flenghi L, Fagioli M, Tomassoni L, Pileri S, Gambacorta M, Pacini R, Grignani F, Casini T, Ferrucci PF, Martelli MF, Pelicci P-G, Falini B (1995) Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85: 1871 – 1880
Forman BM, Umesono K, Chen J, Evans RM (1995) Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81: 541 – 550
Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP (1992) The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann Intern Med 117: 292 – 296
Freemont PS, Hanson IM, Trowsdale J (1991) A novel cysteine-rich sequence motif. Cell 64: 483 – 484
Freemont PS (1993) The RING Finger. A novel protein sequence motif related to the zinc finger. Ann NY Acad Sci 684: 174 – 192
Fukutani H, Naoe T, Ohno R, Yoshida H, Miyawaki S, Shimazaki C, Miyake T, Nakayama Y, Kobayashi H, Goto S, Takeshita A, Kobayashi S, Kato Y, Shiraishi K, Sasada M, Ohtake S, Murakami H, Kobayashi S, Endo N, Shindo H, Matsushita K, Hasegawa S, Tsuji K, Ueda Y, Tominaga N, Furuya H, Inoue Y, Takeuchi J, Morishita H, Iida H (1995) Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. Leukemia 9: 1478 – 1482
Gallagher RE, Li Y-P, Rao S, Paietta E, Andersen J, Etkind P, Bennett JM, Tallman MS, Wiernik PH (1995) Characterization of acute promyelocytic leukemia cases with PML-RARα break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-transretinoic acid. Blood 86: 1540 – 1547
Giguere V, Ong ES, Segui P, Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330: 624 – 629
Goddard AD, Borrow J, Freemont PS, Solomon E (1991) Characterization of a zinc finger gene disrupted by the t(15; 17) in acute promyelocytic leukemia. Science 254: 1371 – 1374
Golomb HM, Rowley JD, Vardiman JW, Testa JR, Butler A (1980) “Microgranular” acute promyelocytic leukemia: a distinct clinical, ultrastructural and cytogenetic entity. Blood 55: 253–259
Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Peschle C, Nicoletti I, Pelicci PG (1993) The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74: 423 – 431
Grimwade D, Howe K, Langabeer S, Burnett A, Goldstone A, Solomon E (1996a) Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RARαand RARα-PML assessment in patients who ultimately relapse. Leukemia 10: 61 – 66
Grimwade D, Howe K, Langabeer S, Burnett A, Goldstone A, Solomon E (1996a) Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RARαand RARα-PML assessment in patients who ultimately relapse. Leukemia 10: 61 – 66
Hiorns LR, Min T, Swansbury GJ, Zelent A, Dyer MJS, Catovsky D (1994) Interstitial insertion of retinoic acid receptor-α gene in acute promyelocytic leukaemia with normal chromosomes 15 and 17. Blood 83: 2946 – 2951
Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK, Rosenfeld MG (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397 – 404
Huang M-E, Ye Y-C, Chen S-R, Chai J-R, Lu J-X, Zhoa L, Gu L-J, Wang Z-Y (1988) Use of all-transretinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567 – 572
Huang W, Sun G-L, Li X-S, Cao Q, Lu Y, Jang G-S, Zhang F-Q, Chai J-R, Wang Z-Y, Waxman S, Chen Z, Chen S-J (1993) Acute promyelocytic leukemia: clinical relevance of two major PML/RARa isoforms and detection of minimal residual disease by retro-transcriptase polymerase chain reaction to detect relapse. Blood 82: 1264 – 1269
Imakado S, Bickenbach JR, Bundman DS, Rothnagel JA, Attar PS, Wang X-J, Walczak VR, Wisniewski S, Pote J, Gordon JS, Heyman RA, Evans RM, Roop DR (1995) Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev 9: 317 – 329
Jones JS, Weber S, Prakash L (1988) The Saccharomyces cerevisiaeRAD 18 gene encodes a protein that contains potential zinc finger domains for nucleic acid binding and a putative nucleotide binding sequence. Nucleic Acids Res 16: 7119 – 7131
Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VWS, Dmitrovsky E, Evans RM (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66: 663 – 674
Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub M-P, Durand B, Lanotte M, Berger R, Chambon P (1992) Structure, localisation and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J 11: 629 – 642
Kastner P, Grondona JM, Mark M, Gansmuller A, LeMeur M, Decimo D, Vonesch J-L, Dolle P, Chambon P (1994) Genetic analysis of RXRα developmental function: convergence of RXR and RAR signalling pathways in heart and eye morphogenesis. Cell 78: 987 – 1003
Kelly C, Vandriel R, Wilkinson GWG (1995) Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J Gen Virol 76: 2887 – 2893
Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM (1992) Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature: 355, 446 – 449
Koken MHM, Puvion-Dutilleul F, Guillemin MC, Viron A, Linares-Cruz G, Stuurman N, de Jong L, Szostecki C, Calvo F, Chomienne C, Degos L, Puvion E, de Thé H (1994) The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J 13: 1073 – 1083
Koken MHM, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thépot J, Juhlin L, Degos L, Calvo F, de Thé H (1995) The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10: 1315 – 1324
Korioth F, Gieffers C, Maul GG, Frey J (1995) Molecular characterization of NDP52, a novel protein of the Nuclear Domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol 130: 1–13
Korninger L, Knobl P, Laczika K, Mustafa S, Quehenberger P, Schwarzinger I, Lechner K, Jaeger U, Mannhalter C (1994) PML-RARα PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2–3 months. Br J Haematol 88: 427 – 431
Kurokawa R, DiRenzo J, Boehm M, Sugarman J, Gloss B, Rosenfeld MG, Heyman RA, Glass CK (1994) Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371: 528 – 531
Kurokawa R, Söderström M, Hörlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK (1995) Polarity- specific activities of retinoic acid receptors determined by a co-repressor. Nature 377: 451 – 454
Lanotte M, Martin V, Najman S, Ballerini P, Valensi S, Berger R (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human promyelocytic leukemia (M3). Blood 77: 1080 – 1086
Le Douarin B, Zechel C, Gamier J-M, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R (1995) The N-terminal part of TIFI, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. Embo J 14: 2020 – 2033
Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu XP, Haefner P, Dawson MI, Pfahl M (1992) Retinoids selective for retinoid X receptor response pathways. Science 258: 1944 – 1946
Leid M, Kastner P, Chambon P (1992a) Multiplicity generates diversity in the retinoic acid signaling pathways. TIBS 17: 427 – 433
Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen J-Y, Staub A, Gamier J-M, Mader S, Chambon P (1992b) Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377 – 395
Lemons RS, Eilender D, Waldmann RA, Robentisch M, Frej AK, Ledbetter DM, Willman C, McConnel P (1990) Cloning and characterisation of the t(15;17) translocation breakpoint region in acute promyelocytic leukemia. Genes Chromosom Cancer 2: 79 – 87
Leroy P, Krust A, Zelent A, Mendelsohn C, Gamier J-M, Kastner P, Dierich A, Chambon P (1991) Multiple isoforms of the mouse retinoic acid receptor a are generated by alternative splicing and differential induction by retinoic acid. EMBO J 10: 59 – 69
Licht JD, Chomienne C, Goy A, Chen A, Scott AA, Head DR, Michaux JL, Wu Y, DeBiasio A, Miller WH, Zelenetz AD, Willman CL, Chen Z, Chen S-J, Zelent A, Macintyre E, Veil A, Cortes J, Kantarjian H, Waxman S (1995) Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). Blood 85: 1083 – 1094
Linch DC, Fine LG, Fielding A, Machin SJ, Goldstone AH, Solomon E, Gann E (1994) Acute promyelocytic leukaemia. Lancet 344: 1615 – 1618
Liu J-H, Mu Z-M, Chang KS (1995) PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J Exp Med 181: 1965 – 1973
Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T, Pelicci PG (1992) Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 340: 1437 – 1438
Longo L, Pandolfi PP, Biondi A, Rambaldi A, Mencarelli A, Lo Coco F, Diverio D, Pegoraro L, Avanzi G, Tabilio A, Zangrilli D, Alcalay M, Donti E, Grignani F, Pelicci PG (1990) Rearrangements and aberrant expression of the retinoic acid α gene in acute promyelocytic leukemias. J Exp Med 172: 1571 – 1575
Longo L, Trecca D, Biondi A, Lo Coco F, Grignani F, Maiolo MA, Pelicci PG, Neri A (1993) Frequency of RAS and p53 mutations in acute promyelocytic leukemias. Leuk Lymphoma 11: 405 – 410
Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352: 497 – 505
McKenna RW, Parkin J, Bloomfield CD, Sundberg RD, Brunning RD (1982) Acute promyelocytic leukaemia: a study of 39 cases with identification of a hyperbasophilic microgranular variant. Br J Haematol 50: 201 – 214
McKinney CD, Golden WL, Gemma NW, Swerdlow SH,Williams ME (1994) RARA and PML gene rearrangements in acute promyelocytic leukaemia with complex translocations and atypical features. Genes Chromosom Cancer 9: 49 – 56
Maslak P, Miller WH, Heller G, Scheinberg DA, Dmitrovsky E, Warreil RP (1993) CD2 expression and PML RAR-a trancripts in acute promyelocytic leukemia. Blood 81: 1666 – 1667
Mermod N, O’Neill EA, Kelly TJ, Tjian R (1989) The proline-rich transcriptional activator of CTF/NF-1 is distinct from the replication and DNA binding domain. Cell 58: 741 – 753
Miki T, Fleming TP, Crescenzi M, Molloy CJ, Blam SB, Reynolds SH, Aaronson SA (1991) Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. Proc Natl Acad Sci USA 88: 5167 – 5171
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66 – 71
Miller WH, Kakizuka A, Frankel SR, Warrell RP, DeBiasio A, Levine K, Evans R, Dmitrovsky E (1992) Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89: 2694 – 2698
Miller WH, Levine K, DeBiasio A, Frankel SR, Dmitrovsky E, Warrell RP (1993) Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-a fusion mRNA. Blood 82: 1689 – 1694
Mitchell PJ, Tjian R (1989) Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245: 371 – 378
Mitelman F (1994) Catalog of chromosomal aberrations in cancer 5th edn Liss, New York, pp: 2489–2499; 2759–2769
Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT (1994) Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin’s lymphoma. Science 263: 1281 - 1284
Mu Z-M, Chin K-V, Liu J-H, Lozano G, Chang K-S (1994) PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol Cell Biol 14: 6858 – 6867
Nagpal S, Saunders M, Kastner P, Durand B, Nakshatri H, Chambon P (1992) Promoter context-andresponse element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70: 1007 – 1019
Nucifora G, Larson RA, Rowley JD (1993) Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 82: 712 – 715
Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH (1994) The immunophenotype of acute promyelocytic leukemia (APL): and ECOG study. Leukemia 8: 1108–1112 Pandolfi PP, Grignani F, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Grignani F, Pelicci PG (1991) Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene 6: 1285 – 1292
Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F, Rochette-Egly C, Gaube M-P, Chambon P, Pelicci PG (1992) Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukaemia. EMBO J 11: 1397 – 1407
Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P (1993) PML/RAR homodimers: distinct DNA binding properties and heteromeric interaction with RXR. EMBO J 12: 3171 – 3182
Preston RA, Manolson MF, Becherer K, Weidenhammer E, Kirkpatrick D, Wright R, Jones EW (1991) Isolation and characterization of PEP3, a gene required for vacuolar biogenesis in Saccharomyces cerevisiae. Mol Cell Biol 11: 5801 – 5812
Puvion-Dutilleul F, Chelbi-Alix MK, Koken M, Quignon F, Puvion E, de Thé H (1995) Adenovirus infection induces rearrangements in the intranuclear distribution of the nuclear body-associated PML protein. Exp Cell Res 218: 9 – 16
Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ (1996) The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 87: 882 – 886
Robertson KA, Emami B, Collins SJ (1992a) Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80: 1885 – 1889
Robertson KA, Emami B, Mueller L, Collins SJ (1992b) Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells. Mol Cell Biol 12: 3743 – 3749
Robinson JS, Graham TR, Emr SD (1991) A putative zinc finger protein, Saccharomyces cerevisiaeVps18p, affects late Golgi functions required for vacuolar protein sorting and efficient α-factor prohormone maturation. Mol Cell Biol 12: 5813 – 5824
Rodeghiero F, Castaman G (1994) The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia. Leukemia 8 (Suppl): s20 – s26
Rowley JD, Golomb HM, Dougherty C (1977) 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1: 549–550
Saitou M, Sugai S, Tanaka T, Shimouchi K, Fuchs E, Narumiya S, Kakizuka A (1995) Inhibition of skin development by targeted expression of a dominant negative retinoic acid receptor. Nature 374: 159 – 162
Sakashita A, Kizaki M, Pakkala S, Schiller G, Tsuruoka, Tomosaki R, Cameron JF, Dawson MI, Koeffler HP (1993) 9-cis-retinoic acid: effects on normal and leukaemic haematopoiesis in vitro. Blood 81:1009–1016
Sarkar A, Yang P, Fan Y-H, Mu Z-M, Hauptmann R, Adolf GR, Stass SA, Chang K-S (1994) Regulation of the expression of annexin VIII in acute promylocytic leukemia. Blood 84: 279 – 286
Sawyers CL, Denny CT, Witte ON (1991) Leukemia and the disruption of normal haematopoiesis. Cell 64: 337 – 350
Schatz DG, Oettinger MA, Baltimore D (1989) The V(D)J recombination activating gene, RAG-1. Cell 59: 1035 – 1048
Schrader M, Wyss A, Sturzenbecker LJ, Grippo JF, LeMotte P, Carlberg C (1993) RXR-dependent and RXR-independent transactivation by retinoic acid receptors. Nucleic acid Res 21: 1231 – 1237
Schwabe JWR, Chapman L, Finch JT, Rhodes D (1993) The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements. Cell 75: 567 – 578
Seale J, Marcus R, Janossy G, Swirsky D, Goldman J, Cross N, Pandolfi PP (1994) Quantitative assessment of minimal residual disease in acute promyelocytic leukemia by RT-PCR: Evaluation of techniques to improve sensitivity. Blood 84 (Suppl): 301a
Stadler M, Chelbi-Alix MK, Koken MHM, Venturini L, Lee C, Säib A, Quignon F, Pelicano L, Guillemin M-C, Schindler C, de Thé H (1995) Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11: 2565 – 2573
Stone RM, Mayer RJ (1990) The unique aspects of acute promyelocytic leukemia. J Clin Oncol 8: 1913 – 1921
Stunnenberg HG (1993) Mechanisms of transactivation by retinoic acid receptors. Bioessays 15: 309 – 315
Stuurman N, de Graaf A, Floore A, Josso A, Humbel B, de Jong L, van Driel R (1992) A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J Cell Sc 101: 773 – 784
Sucov HM, Dysøn E, Gumeringer CL, Price J, Chien KR, Evans RM, (1994) RXRα mutant mice establish a genetic basis for vitamin A signalling in heart morphogenesis. Genes Dev 8: 1007 – 1018
Swansbury GJ, Lawler SD, Alimena G, Arthur D, Berger R, Van Den Berghe H, Bloomfield CD, de la Chapelle A, Dewald G, Garson OM, Hagemeijer A, Mitelman F, Rowley JD, Sakurai M (1994) Long-term survival in acute myelogenous leukemia: A second follow-up of the fourth international workshop on chromosomes in leukemia. Cancer Genet Cytogenet 73: 1 – 7
Takahashi M, Inaguma Y, Hiai H, Hirose F (1988) Developmentally regulated expression of a human finger-containing gene encoded by the 5′ half of the ret transforming gene. Mol Cell Biol 8: 1853 - 1856
Tallman MS, Kwaan HC (1992) Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 79: 543 – 553
Tashiro S, Kotomura N, Tanaka K, Suzuki K, Kyo T, Dohy H, Niwa O, Kamada N (1994) Identification of illegitimate recombination hot spot of the retinoic acid receptor alpha gene involved in 15; 17 chromosomal translocation of acute promyelocytic leukemia. Oncogene 9: 1939 – 1945
Terris B, Baldin V, Dubois S, Degott C, Flejou J-F, Henin D, Dejean A (1995) PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res 55: 1590 – 1597
Testa U, Grignani F, Barberi T, Fagioli M, Masciulli R, Ferruci PF, Seripa D, Camagna A, Alcalay M, Pelicci PG, Peschle C (1994) PML/RARα+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3. Cancer Res 54: 4508 - 4515
Tobal K, Liu Yin JA (1995) Detection of persistent PML-RARα positive cells in long term remission of acute promyelocytic leukaemia (APL) by a sensitive “hot start” RT-PCR. Br J Haematol 89 (Suppl): 59
Tsai S, Collins SJ (1993) A dominant retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad USA 90: 7153 – 7157
Umesono K, Murakami KK, Thompson CC, Evans RM (1991) Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65: 1255 – 1266
Vahdat L, Maslak P, Miller WH, Eardley A, Heller G, Scheinberg DA, Warreil RP (1994) Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: Impact of leukocytosis, low-dose chemotherapy, PML-RAR-α isoform, and CD 13 expression in patients treated with all-transretinoic acid. Blood 84: 3843 – 3849
Warrell RP (1993) Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. Blood 82: 1949 – 1953
Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A (1994) Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukaemia cells. Cell 76: 345 – 356
Woolford CA, Dixon CK, Manolson MF, Wright R, Jones EW (1990) Isolation and characterization of PEP5, a gene essential for vacuolar biogenesis in saccharomyces cerevisiae. Genetics 125: 739 – 752
Zhang X-K, Hoffmann B, Tran P B-V, Graupner G, Pfahl M (1992) Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441 – 446
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Grimwade, D., Solomon, E. (1997). Characterisation of the PML/RARα Rearrangement Associated with t(15;17) Acute Promyelocytic Leukaemia. In: Rauscher, F.J., Vogt, P.K. (eds) Chromosomal Translocations and Oncogenic Transcription Factors. Current Topics in Microbiology and Immunology, vol 220. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60479-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-60479-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64424-5
Online ISBN: 978-3-642-60479-9
eBook Packages: Springer Book Archive